Neuromyelitis optica spectrum disorder
Medical condition / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Neuromyelitis optica spectrum disorder?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Neuromyelitis optica spectrum disorders (NMOSD) are a spectrum of autoimmune diseases characterized by acute inflammation of the optic nerve (optic neuritis, ON) and the spinal cord (myelitis).[1][2][3] Episodes of ON and myelitis can be simultaneous or successive. A relapsing disease course is common, especially in untreated patients.[1][4]
- Neuromyelitis optica (NMO) is a particular disease within the NMOSD spectrum. It is characterised by optic neuritis and longitudinally extensive myelitis. In more than 80% of NMO cases, the cause is immunoglobulin G autoantibodies to aquaporin 4 (anti-AQP4), the most abundant water channel protein in the central nervous system.[5][1][4]
Quick Facts Other names, Specialty ...
Neuromyelitis optica spectrum disorders | |
---|---|
Other names | Neuromyelitis optica (NMO), Devic's disease, Devic's syndrome |
Specialty | Neurology, ophthalmology |
Symptoms | Vision loss, sensory loss, weakness, bladder dysfunction |
Usual onset | Median: age 40 for AQP4-IgG, age 31 for MOG-IgG[1] |
Types | AQP4-IgG-positive, MOG-IgG-positive (recurrent, monophasic)[1] |
Risk factors | Female sex, genetic factors[1] |
Diagnostic method | Symptoms, blood antibody titers, MRI |
Differential diagnosis | Multiple sclerosis, various autoimmune disorders |
Medication | Eculizumab, inebilizumab, satralizumab, rituximab, methylprednisolone, azathioprine, cellCept, mitoxantrone, methotrexate, intravenous immunoglobulin, cyclophosphamide |
Frequency | Up to 1 in 10,000[1] |
Close